 
About the Program:
Program Overview:
The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 12th IAS Conference on HIV Science (IAS 2023). This program consists of two components: (1) CME Internet Symposium: IAS 2023 Expert Review: a CME Internet symposium that features an overview of key presentations and posters, selected by the expert faculty and (2) Rapid-Fire Review of IAS 2023: a podcast that provides a brief, audio summary of the most essential data presented at the conference.
The Rapid-Fire Review of IAS 2023 features
our national faculty panel briefly reviewing the most essential
information and data from IAS 2023. This activity will enable
participating health care providers caring for HIV-infected patients to
become aware of and understand the data presented at this important
conference and appropriately utilize those data to improve patient care.
All online components of the program can be accessed at www.viraled.com
This
program is produced by the Postgraduate Institute for Medicine and
ViralEd, Inc. It is not a session created by or presented at IAS 2023 and it is not sanctioned by the organizers of IAS 2023.
Target Audience:
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.
Learning Objectives:
After completing this activity, the participant should be better able to:
- Describe and apply in a clinical setting the most current HIV prevention and treatment approaches and paradigms
- Improve retention of patients on ARV therapy by addressing ARV side effects that can interfere with adherence to ARV regimens
- Support the rapid initiation of appropriate and effective antiretroviral therapy
- Characterize new antiretroviral agents in development and how they may be used in the treatment of people with HIV infection
Release Date: July 28, 2023
Expiration Date: July 28,2023
Estimated time to complete the Podcast: 45 minutes
Media: Internet, Phone, Tablet
Faculty:
|
José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain
|
Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom
|
Jürgen Rockstroh, MD
Professor of Medicine
Department of Medicine
University Hospital
Bonn, Germany
|
Renslow Sherer, MD
Professor of Medicine,
Section of Infectious Diseases and Global Health,
University of Chicago
Chicago, Illinois |
Joint Accreditation and Credit Designation Statement:
 |
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
| The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this
activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary
business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Jose Arribas, MD
- Speakers Bureau/Honoraria for non-CME: ViiV, Gilead, MSD
- Consultant/Advisory Board: ViiV, GSK, JAnssen, Gilead, MSD, Aelix, Serono, Lilly, Roche
Graeme Moyle, MD
- Grant/Research Support: NEAT Foundation, ViiV
- Speakers Bureau/Honoraria for non-CME: Gilead, Merck/MSD, ViiV
- Consultant/Advisory Board: Gilead, Merck/MSD, Theratechnologies, ViiV
Jürgen Rockstroh, MD
- Speakers Bureau/Honoraria for non-CME: Gilead, Janssen, Merck, ViiV
- Consultant/Advisory Board: Abivax, Boehringer, Gilead, Merck, ViiV
Renslow Sherer, MD
- Grant/Research Support: Gilead Sciences
The PIM planners and managers have nothing to disclose.
Disclosure of Unlabled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planner. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and
warnings.
Method of Participation and Request for Credit:
1) Go to http://www.cmeuniversity.com/
2) Login or Create a New Account (will take less than 1 minute)
a) If you receive a message when creating a new account that "the
email you entered is already in use", please click the Forgot my
Username or Password link to have your Username and Password sent to you
via email
b) After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
3) Type in 18080 at the top of the page, "Find Post-Test/Evaluation by Course", and click enter
4) Click on the activity title when it appears
5) Choose the type of credit you desire
6) Complete the online Evaluation
7) Receive an immediate CE Certificate to download and/or print for your files
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by
clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable
manufacturer’s product information, and comparison with recommendations of other authorities.
This program has been supported by independent educational grants from Gilead Sciences, Inc. and Merck and Co., Inc.
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at IAS 2023 and it is not sanctioned by IAS 2023.
|
